NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

A potential new topical therapy for the treatment of acute migraine appears safe and effective, according to data that Achelios Therapeutics of Chapel Hill has prepared for presentation at an April 22 neurology conference.

An expanding group of investors has put $50 million worth of skin in the game for Durham-based dermatology products developer Novan Therapeutics.

As we weigh the GSK layoff announcement, let’s be glad for what we have and celebrate what’s to come. Sure, things will never be the same. But the fact is, they never were anyway.

Patheon is adding 488 jobs to its Greenville facility by the end of 2019 as part of a planned $159 million expansion of the site.

The Biomanufacturing and Process Development (BPD) group is dedicated toward providing opportunities for the local bioprocessing group, professionals and students alike, to network, share information and discuss technical issues. As one of the many avenues to do so, we conduct an annual Facility Tour event.

Aerial BioPharma of Morrisville has sold rights to its clinical-stage narcolepsy drug, ADX-N05, for a potential $397 million to Jazz Pharmaceuticals of Dublin, Ireland.

The Nanotech Commercialization Conference, which took place this week in Winston-Salem, offered several panels focused on what makes a successful tech company.

We love to share people’s success stories – especially those in which the North Carolina Biotechnology Center plays an active role. The NCBiotech Jobs Network did just that recently as an Ohio-based contract research and testing company expands its year-old Durham operations. Camargo, needed workers – including a research scientist. Kristi Norris, Ph.D., met Camargo’s vice president of drug development, Gary Barnette, Ph.D., at one of these free monthly get-togethers, and soon thereafter he hired her.

Weekly Grant Funding Opportunities

Visit NCBiotech’s Funding Gateway page to get more information on funding announcements, links to opportunity search databases and grant development tips.

Announcements

uStartups, a new donation crowdfunding site for funding faculty and student research, is ready to accept your donations for 3 projects lead by your peers:

Registration is now open for the 2011 Summer Biotechnology Workshops for Educators. Since 1987, the Summer Workshops have trained more than 1,700 teachers. These teachers have taken the latest biotechnology practices from the workshops back to their classrooms, reaching more than 600,000 students in North Carolina.

Each workshop is one-week and features hands-on activities that engage students and improve learning. Registration is $75 and includes:

Researchers from Durham-based Aldagen have reported positive early clinical study results for two of the firm's lead products, stem cell therapies designed to improve blood flow to the limbs and hearts of people suffering from circulatory problems.

Aldagen is a biopharmaceutical company developing proprietary regenerative cell therapies that target unmet medical needs.

Wes Bonds, Ph.D., a recently retired biotechnology instructor at Western Carolina University who gained nationwide accolades as a creative developer of instructional lessons in genomics, proteomics, DNA sequencing and genetic analysis, died Monday of an apparent heart attack.

Durham-based drug development firm Addrenex Pharmaceuticals has reported positive results from a second Phase III trial of drug candidate Clonicel, which it hopes to market to treat attention deficit hyperactivity disorder (ADHD).

Gwyn Riddick, regional director of the Piedmont Triad office of the North Carolina Biotechnology Center, was recently appointed to serve on the Science Advisory Board (SAB) at UNC Greensboro.

The board's mission is to assist the science departments, research centers and laboratories at UNCG to achieve their goals in government/community relations, professional/industry relations, communications and resource development. Members advise, advocate, and open doors on the university's behalf.

Alyssa LaFaro at UNC Research highlights the coronavirus-focused work of Ralph Baric and Timothy Sheahan, Ph.D.
scroll back to top of page